杜瓦卢马布
医学
阶段(地层学)
放射治疗
回顾性队列研究
癌症
肿瘤科
肺癌
内科学
生物
免疫疗法
古生物学
无容量
作者
Lingjuan Chen,Yi Wen Kong,Fan Tong,Ruiguang Zhang,Peng Ding,Sheng Zhang,Ye Wang,Rui Zhou,Xingxiang Pu,Bolin Chen,Fei Liang,Qiaoyun Tan,Yong‐Min Liang,Lin Wu,Xiaorong Dong
标识
DOI:10.1097/cm9.0000000000003283
摘要
The purpose of this study was to evaluate the safety and efficacy of subsequent radiotherapy (RT) following first-line treatment with durvalumab plus chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC).
科研通智能强力驱动
Strongly Powered by AbleSci AI